Hubei Biocause Heilen Pharmaceutical Dividend
Dividend criteria checks 2/6
Hubei Biocause Heilen Pharmaceutical is a dividend paying company with a current yield of 3.3%.
Key information
3.3%
Dividend yield
105%
Payout ratio
| Industry average yield | 2.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.480 |
| Earnings per share | CN¥0.46 |
| Dividend yield forecast | n/a |
Recent dividend updates
Recent updates
Earnings Not Telling The Story For Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SZSE:301211)
Aug 07
Hubei Biocause Heilen Pharmaceutical (SZSE:301211) Will Pay A Larger Dividend Than Last Year At CN¥0.48
May 22Hubei Biocause Heilen Pharmaceutical's (SZSE:301211) Promising Earnings May Rest On Soft Foundations
Apr 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 301211 has been paying a dividend for less than 10 years.
Growing Dividend: 301211's dividend payments have increased, but the company has only paid a dividend for 2 years.
Dividend Yield vs Market
| Hubei Biocause Heilen Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (301211) | 3.3% |
| Market Bottom 25% (CN) | 0.7% |
| Market Top 25% (CN) | 2.6% |
| Industry Average (Pharmaceuticals) | 2.0% |
| Analyst forecast (301211) (up to 3 years) | n/a |
Notable Dividend: 301211's dividend (3.3%) is higher than the bottom 25% of dividend payers in the CN market (0.73%).
High Dividend: 301211's dividend (3.3%) is in the top 25% of dividend payers in the CN market (2.68%)
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (104.5%), 301211's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 301211 is paying a dividend but the company has no free cash flows.